...
首页> 外文期刊>Endocrine. >Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score
【24h】

Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score

机译:与治疗无关的皮肌炎或多发性肌炎中骨质疏松症的风险增加:一项基于人群得分的人群倾向性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We investigated the relationship between dermatomyositis/polymyositis (DM/PM) and the risk of subsequent osteoporosis development. A population-based retrospective cohort analysis was conducted using the National Health Insurance Research Database and the Catastrophic Illness Patients Database of Taiwan. We included 1179 patients and 4716 patients from 1999 to 2008 as the DM/PM cohort and the comparison cohort, respectively, and calculated the incidence rates of newly diagnosed osteoporosis. We used Cox proportional hazards models stratified on matched pair to assess the effect of DM/PM. The Kaplan-Meier method was applied to estimate the cumulative osteoporosis incidence curves. Patients with DM/PM were 2.99 times more likely to experience osteoporosis than those without DM/PM. The risk for osteoporosis in DM/PM patients was higher than comparisons in different propensity score quartiles. DM/PM cohort, no matter treated with or without corticosteroids and immunosuppressant, had a higher risk than the comparison cohort. The incidence of osteoporosis in Taiwan is associated with a priori DM/PM history. This risk was independent of the corticosteroids and immunosuppressant treatment.
机译:我们调查了皮肌炎/多发性肌炎(DM / PM)与随后的骨质疏松症发展风险之间的关系。使用国家健康保险研究数据库和台湾灾难性疾病患者数据库进行了基于人群的回顾性队列分析。我们纳入了1999年至2008年的DM / PM队列和比较队列的1179例患者和4716例患者,并计算了新诊断的骨质疏松症的发病率。我们使用在匹配对上分层的Cox比例风险模型评估DM / PM的效果。应用Kaplan-Meier方法估计累积骨质疏松症发病率曲线。 DM / PM患者发生骨质疏松症的可能性是无DM / PM患者的2.99倍。 DM / PM患者的骨质疏松风险高于不同倾向评分四分位数患者的骨质疏松风险。无论是否使用皮质类固醇和免疫抑制剂治疗,DM / PM队列的患病率均高于对照组。台湾的骨质疏松症的发病率与先天的DM / PM历史有关。这种风险与皮质类固醇和免疫抑制剂的治疗无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号